Details of Host Protein-DME Interaction (HOSPPI)
| General Information of Drug-Metabolizing Enzyme (DME ID: DME0451) | |||||
|---|---|---|---|---|---|
| DME Name | Thyroid peroxidase (TPO), Homo sapiens | DME Info | |||
| UniProt ID | |||||
| EC Number | EC: 1.11.1.8 (Click to Show/Hide the Complete EC Tree) | ||||
| Lineage | Species: Homo sapiens (Click to Show/Hide the Complete Species Lineage) | ||||
| Interactome | |||||
| Disease Specific Interactions between Host Protein and DME (HOSPPI) | |||||
|---|---|---|---|---|---|
| ICD Disease Classification Healthy | |||||
| ICD-11: Healthy | Click to Show/Hide the Full List of HOSPPI: 2 HOSPPI | ||||
| Transcription-factor regulation | |||||
| Hepatocyte NF 3-beta (FOXA2) | Health | Activation | |||
| Uniprot ID | |||||
| Interaction Name | FOXA2-TPO interaction | [1] | |||
| Studied Cell Lines | Thyroid cell line | ||||
| Ensembl ID | |||||
| Description | Hepatocyte NF 3-beta (FOXA2) is reported to activate the transcription of TPO gene, which leads to an increased expression of the drug-metabolizing enzyme Thyroid peroxidase. As a result, the interaction between FOXA2 and TPO can activate the drug-metabolizing process of Thyroid peroxidase. | ||||
| Transcription release 2 (TTF2) | Health | Activation | |||
| Uniprot ID | |||||
| Interaction Name | TTF2-TPO interaction | [1] | |||
| Studied Cell Lines | Thyroid cell line | ||||
| Description | Transcription release 2 (TTF2) is reported to activate the transcription of TPO gene, which leads to an increased expression of the drug-metabolizing enzyme Thyroid peroxidase. As a result, the interaction between TTF2 and TPO can activate the drug-metabolizing process of Thyroid peroxidase. | ||||
| ICD Disease Classification 02 Neoplasms | |||||
| ICD-11: 2E06 Prostate cancer metastasis | Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI | ||||
| DNA methylation | |||||
| DNA methyltransferase (DNMT) | Prostate cancer metastasis | Moderate hypomethylation | |||
| Interaction Name | DNMT-TPO interaction | ||||
| The Methylation Level of Disease Section Compare with the Healthy Individual Tissue | Moderate hypomethylation p-value: 3.91E-02; delta-beta: -2.06E-01 | ||||
| Description | DNA methyltransferase (DNMT) is reported to moderatly hypo-methylate the TPO gene, which leads to a moderatly increased expression of the drug-metabolizing enzyme Thyroid peroxidase. As a result, the interaction between DNMT and TPO can moderatly affect the drug-metabolizing process of Thyroid peroxidase. | ||||
|
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
|
|||||
| Violin Diagram of DME Disease-specific Methylation Level |
|
Click to View the Clearer Original Diagram | |||
| References | |||||
|---|---|---|---|---|---|
| 1 | Hepatocyte nuclear factor 3beta participates in the transcriptional regulation of the thyroperoxidase promoter. Biochem Biophys Res Commun. 1996 Mar 7;220(1):86-93. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

